Skip to main content
. 2009 Jul 7;16(1):61. doi: 10.1186/1423-0127-16-61

Table 1.

Comparisons of oxidants and antioxidants in HIV-1 infected patients.

Controls (MEAN ± S.D) N = 50 HIV-1 Asymptomatic patients (MEAN ± S.D) N = 28 HIV-1 Symptomatic patients (MEAN ± S.D) N = 22 p value
MDA (n mol/mL) 0.9 ± 0.2 2.2 ± 0.7 2.8 ± 0.8 P < 0.01

TAC (μmol/L) 1018.7 ± 125.6 754.6 ± 135.6 676.6 ± 154.1 P < 0.01

Vitamin E (mg/L) 10.0 ± 0.8 8.2 ± 0.6 7.4 ± 0.6 P < 0.01

Vitamin C (mg/dl) 6.3 ± 0.2 5.8 ± 0.2 3.6 ± 0.2 P < 0.01

SOD activity (units/ml) 8.75 ± 1.1 4.9 ± 0.4 3.7 ± 0.4 P < 0.01

MDA – Malondialdehyde, TAC – Total Antioxidant Capacity, SOD – Superoxide Dismutase.

HHS Vulnerability Disclosure